Study on serum osteocalcin and beta-crosslaps of overweight people
Main Article Content
Keywords
Abstract
Objective: To determine on serum osteocalcin and beta-crosslaps of overweight people. Subject and method: The study describes the cross, controlled. Group treatment: 341 patients with BMI ≥ 23, the control group: 129 patients had 18.5 ≤ BMI < 23. Result: The mean OC concentration in the group treatment 14.42 ± 6.55ng/ml was lower in the control group 16.61 ± 7.78ng/ml (p=0.001). The mean BC concentration in the group treatment 0.26 ± 0.22ng/ml was lower than in the control group 0.34 ± 0.25ng/ml (p=0.001). The mean BC and OC concentration in the BMI group ≥ 25 was lower than in the BMI with group 23 < BMI < 25 (p<0.05). Conclusion: Concentration of serum osteocalcin and beta-crosslaps of overweight people is significantly lower than the control group (p<0.001, p<0.001 respectively); and obesity group (p<0.05).
Article Details
References
2. Cooper C, Cole ZA, Holroyd CR et al (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22(5): 1277-1288.
3. Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10): 2359-2381.
4. Kalaiselvi VS, Prabhu K, Ramesh M et al (2013) The association of serum osteocalcin with the bone mineral density in post menopausal women. J Clin Diagn Res 7(5): 814-816.
5. Lynda EP, David RJJR, Brandon MN et al (2012) Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults. PMC 1: 15.
6. Magni P, Dozio E, Galliera E et al (2010) Molecular aspects of adipokine-bone interactions. Curr Mol Med 10(6): 522-532.
7. Rexhepi S, Bahtiri E, Rexhepi M et al (2015) Association of body weight and body mass index with bone mineral density in women and men from kosovo. Mater Sociomed 27(4): 259-262.
8. Wang JW, Tang QY, Ruan HJ et al (2014) Relation between serum osteocalcin levels and body composition in obese children. J Pediatr Gastroenterol Nutr 58(6).
9. Vasikaran SD and Chubb SA (2016) The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis. Endocrine 52(2): 222-225.
10. WHO (2000) Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894: 1-253.